StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Filana Therapeutics's price to sales ratio was 6.3× on Apr 30, 2014, against 17.1× a year earlier. Over the last 2 years it ranged from 6.1× to 26.2×, with a median of 14.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2014Apr 30, 20146.3×−19.9
2013Dec 31, 201326.2×+10.4
2012Apr 30, 201215.8×+3.5
2011Jul 29, 201112.3×–

More Filana Therapeutics figures

See a number that looks wrong?